Di-aspartic acid

• Description :

  Di-aspartic acid (Aspartylaspartate) can be utilized as growth substrate for P. gingivalis, P. intermedia, P. nigrescens and F. nucleatum[1].

• UNSPSC :

  12352209

• Hazard Statement :

  H302-H312-H332

• Target :

  Bacterial

• Type :

  Peptides

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/di-aspartic-acid.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC(C[C@H](N)C(N[C@H](C(O)=O)CC(O)=O)=O)=O

• Molecular Formula :

  C8H12N2O7

• Molecular Weight :

  248.19

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P501

• References & Citations :

  [1]Takahashi N, et al. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum. Oral Microbiol Immunol. 2002 Feb;17 (1) :50-4.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [58471-53-7]